2024 Q4 Form 10-Q Financial Statement

#000141057824001879 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $357.0K
YoY Change -12.07%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $8.130M
YoY Change 12.9%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $8.130M
YoY Change 12.9%
Operating Profit -$14.80M
YoY Change 7.06%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.573M
YoY Change -3.83%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$19.37M
YoY Change 4.27%
Net Earnings / Revenue -5426.89%
Basic Earnings Per Share -$0.02
Diluted Earnings Per Share -$0.02
COMMON SHARES
Basic Shares Outstanding 1.297B 1.248B
Diluted Shares Outstanding 1.259M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.939M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.192M
YoY Change -38.57%
LONG-TERM ASSETS
Property, Plant & Equipment $17.32M
YoY Change 3.41%
Goodwill $626.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $374.0K
YoY Change 4.76%
Total Long-Term Assets $24.13M
YoY Change 4.73%
TOTAL ASSETS
Total Short-Term Assets $5.192M
Total Long-Term Assets $24.13M
Total Assets $29.32M
YoY Change -6.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $59.56M
YoY Change 21.01%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $34.00M
YoY Change 72.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.56M
Total Long-Term Liabilities $34.00M
Total Liabilities $93.56M
YoY Change 35.7%
SHAREHOLDERS EQUITY
Retained Earnings -$1.415B
YoY Change 5.55%
Common Stock $1.335B
YoY Change 4.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$80.12M
YoY Change
Total Liabilities & Shareholders Equity $29.32M
YoY Change -6.89%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$19.37M
YoY Change 4.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember
CY2024Q3 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember
dei Entity Central Index Key
EntityCentralIndexKey
0001072379
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Security Exchange Name
SecurityExchangeName
NONE
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://www.nwbio.com/20240930#ResearchAndOtherRevenueMember
CY2024Q3 nwbo Fair Value Liabilities Level1 To Level2 Transfers Amount1
FairValueLiabilitiesLevel1ToLevel2TransfersAmount1
0
CY2024Q3 nwbo Fair Value Liabilities Level2 To Level1 Transfers Amount1
FairValueLiabilitiesLevel2ToLevel1TransfersAmount1
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2024Q3 nwbo Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2024Q3 nwbo Operating Lease Liability Additions
OperatingLeaseLiabilityAdditions
400000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35737
dei Entity Registrant Name
EntityRegistrantName
NORTHWEST BIOTHERAPEUTICS, INC
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-3306718
dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
dei City Area Code
CityAreaCode
240
dei Local Phone Number
LocalPhoneNumber
497-9024
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
NWBO
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1297445623
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2939000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2126000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2253000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1999000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5192000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4125000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17322000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17278000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4515000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4183000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1292000
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
1292000
CY2024Q3 us-gaap Goodwill
Goodwill
626000
CY2023Q4 us-gaap Goodwill
Goodwill
626000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
374000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
361000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
24129000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
23740000
CY2024Q3 us-gaap Assets
Assets
29321000
CY2023Q4 us-gaap Assets
Assets
27865000
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17913000
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10244000
CY2024Q3 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
3043000
CY2023Q4 nwbo Accounts Payable And Accrued Liabilities Related Parties Current
AccountsPayableAndAccruedLiabilitiesRelatedPartiesCurrent
3544000
CY2024Q3 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
1825000
CY2023Q4 nwbo Convertible Notes Payable Net Current
ConvertibleNotesPayableNetCurrent
3765000
CY2024Q3 nwbo Convertible Notes At Fair Value Current
ConvertibleNotesAtFairValueCurrent
19380000
CY2023Q4 nwbo Convertible Notes At Fair Value Current
ConvertibleNotesAtFairValueCurrent
12771000
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
7577000
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3944000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
9193000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
9188000
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
944000
CY2024Q3 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
207000
CY2023Q4 us-gaap Deferred Compensation Share Based Arrangements Liability Current
DeferredCompensationShareBasedArrangementsLiabilityCurrent
7000
CY2024Q3 nwbo Share Liability
ShareLiability
170000
CY2023Q4 nwbo Share Liability
ShareLiability
483000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
256000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
314000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
59564000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45204000
CY2024Q3 nwbo Convertible Notes At Fair Value Non Current
ConvertibleNotesAtFairValueNonCurrent
3774000
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
20695000
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
20312000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4828000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4454000
CY2024Q3 nwbo Contingent Payment Obligation Noncurrent
ContingentPaymentObligationNoncurrent
4700000
CY2023Q4 nwbo Contingent Payment Obligation Noncurrent
ContingentPaymentObligationNoncurrent
4950000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
33997000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
29716000
CY2024Q3 us-gaap Liabilities
Liabilities
93561000
CY2023Q4 us-gaap Liabilities
Liabilities
74920000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1700000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1700000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1286300000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1286300000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1175500000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1175500000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1286000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1175000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1333981000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1291316000
CY2024Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
79000
CY2023Q4 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
79000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1415276000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1359721000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-29000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1536000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-80117000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-65773000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29321000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27865000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
357000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
406000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1151000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1487000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
357000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
406000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1151000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1487000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8130000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7201000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24365000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20276000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7028000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7030000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24795000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21577000
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
15158000
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
14231000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
49160000
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
41853000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-14801000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13825000
us-gaap Operating Income Loss
OperatingIncomeLoss
-48009000
us-gaap Operating Income Loss
OperatingIncomeLoss
-40366000
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1590000
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-112000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
939000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3875000
CY2024Q3 nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
70000
CY2023Q3 nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
487000
nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
31000
nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
534000
CY2024Q3 nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
3087000
CY2023Q3 nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
-4942000
nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
4621000
nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
-4942000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-6820000
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1768000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9905000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3648000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2080000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1670000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5279000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
3999000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2760000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-1692000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
2047000
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-76000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4573000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9697000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7546000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8256000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-19374000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-23522000
us-gaap Net Income Loss
NetIncomeLoss
-55555000
us-gaap Net Income Loss
NetIncomeLoss
-48622000
CY2024Q3 nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
132000
CY2023Q3 nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
519000
nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
1141000
nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
1433000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-19506000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-24041000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-56696000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50055000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2253000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-1397000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1565000
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-145000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21759000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22644000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58261000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49910000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1258532
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1134359
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1220472
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1106111
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1258532
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1134359
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1220472
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1106111
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-76497000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
4987000
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7114000
CY2024Q3 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
26000
CY2024Q3 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
4868000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
685000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-19374000
CY2024Q3 nwbo Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
459000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
132000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2253000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-80117000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-61034000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2974000
CY2023Q3 nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
32000
CY2023Q3 nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
7920000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
1565000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-23522000
CY2023Q3 nwbo Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
1126000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
519000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1397000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-70061000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-65773000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
13721000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10011000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
1517000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
12968000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
3002000
us-gaap Net Income Loss
NetIncomeLoss
-55555000
nwbo Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
2698000
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1141000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1565000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-80117000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-128103000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6536000
nwbo Value Of Warrants Exercised For Cash
ValueOfWarrantsExercisedForCash
2801000
nwbo Adjustments To Additional Paid In Capital Reclassification
AdjustmentsToAdditionalPaidInCapitalReclassification
76258000
nwbo Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest
StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest
17484000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2673000
us-gaap Net Income Loss
NetIncomeLoss
-48622000
nwbo Adjustments To Additional Paid In Capital Warrants Modification
AdjustmentsToAdditionalPaidInCapitalWarrantsModification
2200000
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1433000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
145000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-70061000
us-gaap Net Income Loss
NetIncomeLoss
-55555000
us-gaap Net Income Loss
NetIncomeLoss
-48622000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1307000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1101000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
1618000
nwbo Amortization Of Debt Discount
AmortizationOfDebtDiscount
2006000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
939000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3875000
nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
31000
nwbo Fair Value Adjustment Of Share Liability
FairValueAdjustmentOfShareLiability
534000
nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
4621000
nwbo Fair Value Adjustment Of Convertible Notes
FairValueAdjustmentOfConvertibleNotes
-4942000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9905000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-3648000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
236000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
211000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
3002000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2833000
nwbo Warrant Modifications Associated With Convertible Notes Under Fair Value Option
WarrantModificationsAssociatedWithConvertibleNotesUnderFairValueOption
327000
nwbo Warrant Modifications Associated With Convertible Notes Under Fair Value Option
WarrantModificationsAssociatedWithConvertibleNotesUnderFairValueOption
287000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
10804000
us-gaap Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
10619000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
216000
nwbo Increase Decrease In Prepaid Expense And Other Current Assets
IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets
-802000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
9000
nwbo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
13000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
8535000
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
2657000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-501000
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-2239000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
106000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
117000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36836000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-36679000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
936000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3019000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-936000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3019000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10011000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1517000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1598000
nwbo Payments To Investors
PaymentsToInvestors
-200000
nwbo Payments To Investors
PaymentsToInvestors
-7000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12000000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
10000000
nwbo Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
9915000
nwbo Proceeds From Issuance Of Convertible Notes Payable
ProceedsFromIssuanceOfConvertibleNotesPayable
12699000
nwbo Proceeds From Contingent Payment Obligation
ProceedsFromContingentPaymentObligation
50000
nwbo Proceeds From Contingent Payment Obligation
ProceedsFromContingentPaymentObligation
4550000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
251000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
210000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
800000
nwbo Repayment Of Investor Advances
RepaymentOfInvestorAdvances
200000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40843000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38343000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2258000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
487000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
813000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-868000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2126000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6965000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2939000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6097000
nwbo Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
3000
nwbo Stock Issued During Period Value For Warrant And Stock Options Cashless Exercise
StockIssuedDuringPeriodValueForWarrantAndStockOptionsCashlessExercise
21000
nwbo Reclassification Of Warrant Liabilities To Stockholders Deficit Non Cash Investing And Financing Activities
ReclassificationOfWarrantLiabilitiesToStockholdersDeficitNonCashInvestingAndFinancingActivities
76258000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
12968000
nwbo Issuance Of Common Stock And Warrants For Conversion Of Debt And Accrued Interest Received
IssuanceOfCommonStockAndWarrantsForConversionOfDebtAndAccruedInterestReceived
17484000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2679000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
13721000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
6536000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
238000
nwbo Capital Expenditures Included In Accounts Payable
CapitalExpendituresIncludedInAccountsPayable
71000
nwbo Issuance Of Convertible Preferred Stock In Lieu Of Debt Redemption
IssuanceOfConvertiblePreferredStockInLieuOfDebtRedemption
1013000
nwbo Deemed Dividend Related To Warrant Modification Non Cash Investing And Financing Activities
DeemedDividendRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
1141000
nwbo Deemed Dividend Related To Warrant Modification Non Cash Investing And Financing Activities
DeemedDividendRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
1433000
nwbo Debt Discount Related To Warrant Modification Non Cash Investing And Financing Activities
DebtDiscountRelatedToWarrantModificationNonCashInvestingAndFinancingActivities
8000
nwbo Reclassification Between Contingent Payment Obligation And Convertible Notes Payable At Fair Value
ReclassificationBetweenContingentPaymentObligationAndConvertibleNotesPayableAtFairValue
300000
nwbo Reclassification Of Investor Advances To Convertible Notes Payable
ReclassificationOfInvestorAdvancesToConvertibleNotesPayable
1163000
nwbo Reclassification Of Investor Advances To Stockholders Deficit
ReclassificationOfInvestorAdvancesToStockholdersDeficit
1203000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
us-gaap Profit Loss
ProfitLoss
-55600000
us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
36800000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Revision of Prior Period Consolidated Financial Statements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">As previously disclosed in the 2023 Annual Report, the Company revised its prior period financial statements to reflect an adjustment related to the fair value of convertible notes that was not material, individually or in the aggregate, to the Company’s previously issued consolidated financial statements. The appropriate revisions to the Company’s historical condensed consolidated financial statements and the notes thereto are reflected herein. See Note 14 to the “Consolidated Financial Statements” in the 2023 Annual Report for additional information.</span></p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">On an ongoing basis, the Company evaluates its estimates and judgments, including valuing equity securities in share-based payment arrangements, estimating the fair value of financial instruments recorded as derivative liabilities, useful lives of depreciable assets, and whether impairment charges may apply. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the reported amounts of revenues and expenses that are not readily apparent from other sources. Actual results could differ from those estimates.</span></p>
CY2024Q3 nwbo Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
23386000
nwbo Fair Value Of Additional Share Liability
FairValueOfAdditionalShareLiability
543000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
8615000
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Debt Redemption
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDebtRedemption
-825000
nwbo Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Additions From Debt Extinguishment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAdditionsFromDebtExtinguishment
7189000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
800000
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-5591000
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
32517000
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
689000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1622000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2980000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2833000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2200000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
317076000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
114097000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.53
nwbo Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P3Y8M12D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
650000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.35
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
316926000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.35
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9558000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
282679000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.33
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
8718000
CY2024Q3 nwbo Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Subject To Block Letter Agreements
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumberSubjectToBlockLetterAgreements
153000000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
283000000
nwbo Share Based Compensation Arrangement By Share Based Payment Award Period Of Notice For Exercising Any Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardPeriodOfNoticeForExercisingAnyOption
P61D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.53
CY2024Q3 nwbo Share Based Compensation Arrangement By Share Based Payment Award Additional Payment Per Option To Be Made For Exercise Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalPaymentPerOptionToBeMadeForExerciseOfOption
0.30
CY2024Q3 nwbo Share Based Compensation Arrangement By Share Based Payment Award Additional Payment To Be Made For Exercise Of Option
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalPaymentToBeMadeForExerciseOfOption
150000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.53
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.045
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17322000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17278000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1100000
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
51838000
CY2024Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1566000
CY2024Q3 nwbo Fair Value Adjustment Convertible Notes At Fair Value
FairValueAdjustmentConvertibleNotesAtFairValue
2979000
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
53251000
CY2023Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
40769000
CY2023Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1998000
CY2023Q4 nwbo Fair Value Adjustment Convertible Notes At Fair Value
FairValueAdjustmentConvertibleNotesAtFairValue
2021000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
40792000
us-gaap Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
800000
nwbo Accrued Share Liabilities
AccruedShareLiabilities
500000
us-gaap Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost
GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost
-3000000.0
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2700000
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
200000
CY2024Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
2100000
CY2023Q3 us-gaap Interest And Debt Expense
InterestAndDebtExpense
1700000
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
600000
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
700000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
5300000
us-gaap Interest And Debt Expense
InterestAndDebtExpense
4000000.0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1600000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2000000.0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
505877000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500497000
nwbo Percentage Of Margin
PercentageOfMargin
0.15
nwbo Ancillary Services Agreement Additional Term Of Agreement
AncillaryServicesAgreementAdditionalTermOfAgreement
P12M
CY2024Q3 us-gaap Area Of Land
AreaOfLand
88000
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
36000
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
36000
us-gaap Sublease Income
SubleaseIncome
109000
us-gaap Sublease Income
SubleaseIncome
108000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2700000
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
200000
CY2024Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
200000
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.40
nwbo Proceeds From Outstanding Warrant Exercises Including Investor Advances
ProceedsFromOutstandingWarrantExercisesIncludingInvestorAdvances
1500000
nwbo Stock Issued During Period Shares Warrant Exercises
StockIssuedDuringPeriodSharesWarrantExercises
6400000
nwbo Number Of Options Cash Less Exercise
NumberOfOptionsCashLessExercise
700000
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
105241000
CY2023Q4 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.31
CY2023 nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P1Y9M29D
nwbo Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
244000
CY2024Q3 nwbo Class Of Warrant Or Rights Granted Weighted Average Exercise Price
ClassOfWarrantOrRightsGrantedWeightedAverageExercisePrice
0.40
nwbo Number Of Warrants Warrants Exercised For Cash
NumberOfWarrantsWarrantsExercisedForCash
6421000
nwbo Weighted Average Exercise Price Exercised For Cash
WeightedAverageExercisePriceExercisedForCash
0.24
nwbo Number Of Warrants Warrants Cashless Exercise
NumberOfWarrantsWarrantsCashlessExercise
4794000
nwbo Weighted Average Exercise Price Warrants Cashless Exercise
WeightedAverageExercisePriceWarrantsCashlessExercise
0.27
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
94270000
CY2024Q3 nwbo Class Of Warrant Or Right Outstanding Weighted Average Exercise Price
ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice
0.28
nwbo Class Of Warrant Or Right Outstanding Remaining Contractual Term
ClassOfWarrantOrRightOutstandingRemainingContractualTerm
P2Y29D
nwbo Class Of Warrant Or Right Extended In Suspension
ClassOfWarrantOrRightExtendedInSuspension
90000000
nwbo Share Based Payment Arrangement Plan Modification Associated With Debt Financing As Additional Debt Discount
ShareBasedPaymentArrangementPlanModificationAssociatedWithDebtFinancingAsAdditionalDebtDiscount
1600000
nwbo Deemed Dividend Related To Warrant Modification
DeemedDividendRelatedToWarrantModification
1100000
CY2024Q3 us-gaap Lease Practical Expedient Lessor Single Lease Component
LeasePracticalExpedientLessorSingleLeaseComponent
true
CY2024Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2024Q3 nwbo Operating Lease Right Of Use Asset Additions
OperatingLeaseRightOfUseAssetAdditions
400000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5100000
CY2024Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P20Y
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4500000
CY2024Q3 us-gaap Area Of Land
AreaOfLand
88000
us-gaap Operating Lease Cost
OperatingLeaseCost
661000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
39000
us-gaap Variable Lease Cost
VariableLeaseCost
24000
us-gaap Sublease Income
SubleaseIncome
109000
us-gaap Lease Cost
LeaseCost
615000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
364000
us-gaap Operating Lease Payments
OperatingLeasePayments
704000
us-gaap Operating Lease Cost
OperatingLeaseCost
633000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
62000
us-gaap Variable Lease Cost
VariableLeaseCost
10000
us-gaap Sublease Income
SubleaseIncome
108000
us-gaap Lease Cost
LeaseCost
597000
us-gaap Operating Lease Payments
OperatingLeasePayments
691000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
174000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
929000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
886000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
696000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
696000
CY2024Q3 nwbo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
6940000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
10321000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5237000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
5084000
CY2022Q3 nwbo Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
135000
CY2022Q3 nwbo Litigation Settlement Waiver Of Penalty
LitigationSettlementWaiverOfPenalty
145000
CY2023Q4 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
189000
CY2023Q4 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
201000
CY2024Q1 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
189000
CY2024Q1 us-gaap Loss Contingency Accrual Payments
LossContingencyAccrualPayments
207000
CY2024Q3 nwbo Accrued Income Tax Liability Trade Tax
AccruedIncomeTaxLiabilityTradeTax
155000
CY2024Q3 nwbo Accrued Income Tax Liability Trade Tax
AccruedIncomeTaxLiabilityTradeTax
173000
CY2024Q3 nwbo Accrued Income Tax Liability Corporation Tax
AccruedIncomeTaxLiabilityCorporationTax
99000
CY2024Q3 nwbo Accrued Income Tax Liability Corporation Tax
AccruedIncomeTaxLiabilityCorporationTax
110000
CY2024Q3 us-gaap Former Gain Contingency Recognized In Current Period
FormerGainContingencyRecognizedInCurrentPeriod
50000000
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001410578-24-001879-index-headers.html Edgar Link pending
0001410578-24-001879-index.html Edgar Link pending
0001410578-24-001879.txt Edgar Link pending
0001410578-24-001879-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwbo-20240930.xsd Edgar Link pending
nwbo-20240930x10q.htm Edgar Link pending
nwbo-20240930xex31d1.htm Edgar Link pending
nwbo-20240930xex32d1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
nwbo-20240930_cal.xml Edgar Link unprocessable
nwbo-20240930_def.xml Edgar Link unprocessable
nwbo-20240930_lab.xml Edgar Link unprocessable
nwbo-20240930_pre.xml Edgar Link unprocessable
nwbo-20240930x10q_htm.xml Edgar Link completed
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable